BUSINESS● LOWAug 5 · Aug 5, 2026, 11:32 AM
Seres Therapeutics EPS of $0.47, revenue of $0.74M beats by $0.56M
Seeking Alpha Tech
Seres Therapeutics reported EPS and revenue that both surpassed analyst expectations. This financial update provides information on the company's recent fiscal performance.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESSnowMines, telecoms, factories… Will African industrialists succeed in doing without diesel?Jeune AfriqueBUSINESS22m agoAlvotech wins FDA nod for new manufacturing process for Humira biosimilarSeeking Alpha Tech